HiberCell Competitors and Similar CompaniesClear all
Eisbach Bio's competitors and similar companies include PEP-Therapy and Rain Therapeutics.
 Eisbach Bio Eisbach Bio is a company that develops drugs to target molecular vulnerabilities arising in cancer genomes. |  PEP-Therapy PEP-Therapy is a medical biotechnology company, that develops peptides as targeted therapies for severe diseases, with an initial focus on cancer. |  Rain Therapeutics Rain Therapeutics is a biotechnology company focused on developing small molecule targeted therapeutics for cancer patients. | |
Founding Date | Founding Date 2019 | Founding Date 2014 | Founding Date 2017 |
Type | Type Private | Type Private | Type Public |
Tags | |||
Locations | Locations Planegg, DE HQ | Locations Paris, FR HQ Évry, FR | Locations Newark, US HQ |
Employees | Employees 118% decrease | Employees 14 | Employees 6343% increase |
Funding | |||
Total funding raised | Total funding raised N/A | Total funding raised $ 3m | Total funding raised $ 82.4m |
For sources of this data, please see the company profile
View Company Profiles
PEP-Therapy
HQ
Paris, FR
Employees
14
PEP-Therapy is a medical biotechnology company, that develops peptides as targeted therapies for severe diseases, with an initial focus on cancer.
View companyRain Therapeutics
HQ
Newark, US
Employees
63↑ 43% increase
Rain Therapeutics is a biotechnology company focused on developing small molecule targeted therapeutics for cancer patients.
View company